跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Coldezent Reformulated - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Coldezent Reformulated
Approved
STANDARD
Coldezent Reformulated
San Marino Laboratories Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
09f767fbd23a585e
Company
San Marino Laboratories Corporation
Type
Standard
Approval Details
Approval Id
09f767fbd23a585e
Drug Approval Philippines Name
Coldezent Reformulated
Product Name
Coldezent Reformulated
Registration Number
DR-XY40302
Brand Name
Coldezent Reformulated
Generic Name
Paracetamol + Phenylephrine Hydrochloride +Chlorphenamine Maleate
Dosage Form
Capsule
Dosage Strength
325mg/ 20mg/ 4mg
Manufacturer
San Marino Laboratories Corporation
Trader
Reach Med Pharma
Issuance Date
26 November 2021
Expiry Date
16 November 2026
Pharmacologic Category
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
09f767fbd23a585e
Type
Standard
Back to Philippines FDA Approvals